Blake Gurfein
CIK 1891888 · Chief Scientific Officer · last filed 2024-12-20
Blake Gurfein is a Chief Scientific Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for TIVC, was dated Dec 20, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Valion Bio, Inc. (TIVC) Delisted | Chief Scientific Officer | — | $1.40 | — | $0 | 5 | 2024-12-20 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-20 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-22 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-10 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-08 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |